TickerFacts.

Company research / OKUR

OnKure Therapeutics, Inc. (OKUR)

Build a valuation ↗↓ Download CSV

CIK 0001637715 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2024-12-31, OnKure Therapeutics, Inc. reported revenue of $0.

Key ratios (year ended 2024-12-31)

-50.7%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4/A · 2026-08-13

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue—$0—————
Operating Income-$62.95M-$54.39M-$36.93M-$53.85M-$39.82M-$19.55M—
Net Income-$59.52M-$52.67M-$35.31M-$51.95M-$39.77M-$19.46M—
EPS (Diluted)$-4.40$-15.28$-124.41$-2.12$-2.19$-9.60—
Total Assets$62.12M$114.91M$35.73M$108.18M$154.02M$55.22M—
Total Liabilities$5.93M$11.08M$7.75M$8.21M$6.81M$4.62M—
Shareholders' Equity$56.18M$103.83M-$101.84M-$54.42M$147.21M-$42.12M-$23.13M
Cash & Equivalents$59.05M$110.76M$29.88M$19.93M$124.66M$53.61M—
Operating Cash Flow-$51.83M-$51.12M-$34.55M-$47.36M-$37.98M-$18.54M—
Capital Expenditures$46.0K$52.0K$246.0K$346.0K$198.0K$24.0K—
Shares Outstanding——33.42M24.70M24.46M2.05M—
Weighted Average Diluted Shares13.52M3.45M283.8K24.50M18.14M2.03M—
EPS (Basic)$-4.40$-15.28$-124.41$-2.12$-2.19$-9.60—